So, Mobocertinib is this EGFR inhibitor thing. It’s mainly used for treating NSCLC in folks with these EGFR exon 20 insertion mutations. The drug works by zeroing in on the EGFR to stop cancer cells from growing.
You take it in these 40 mg capsules. The usual dose is 160 mg a day, and it doesn’t matter if you take it with or without food. It comes in bottles, each with about 90 capsules.
Reviews
There are no reviews yet.